Furthermore, in addition to the current evidence confirming the causal association of Lp(a) with atherogenic CVD as well as CAVD (15, 19, 20), several studies have identified other pathogenic phenotypes of Lp(a). This evidence concerns the gene LPA and congenital bilateral aplasia of vas deferens from CFTR mutation.